Skip to content
10-K

Annual Report

Oruka Therapeutics, Inc. ORKA

0001213900-25-021165

← back to feed
Filed
Mar 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 28, 2025 37.44M sh
Shares Diluted FY 2024 · Dec 31, 2024 16.79M sh
Eps Diluted FY 2024 · Dec 31, 2024 −$3.87
Eps Basic FY 2024 · Dec 31, 2024 −$3.87
Current Assets FY 2024 · Feb 6, 2024 $1K
Total Assets FY 2024 · Feb 6, 2024 $1K
Stockholders Equity FY 2024 · Feb 5, 2024 $1K